Stem cells from HD patients: becoming important tools for researchers - and now correcting the HD mutation in the lab
Silencing the Huntingtin gene using ASO drugs reaches further, lasts longer and is safe. Human trial soon?
CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.
HD patients are less likely to get cancer, according to a study from Sweden - what does this mean?
HDBuzz looks back at the 2012 Huntington's Disease Therapeutics Conference
The Huntington's Disease Youth Organization website has just launched and its website is now active at www.hdyo.org
Looking back at a year in Huntington's disease research - and the first year of HDBuzz
Follow-up data from TRACK-HD study proves that we have the tests we need to successfully run drug trials for HD
HDAC inhibitors explained, plus how new HDAC-related Huntington's disease research might help us find biomarkers